Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2017, Issue -, Pages 1-9
Publisher
Hindawi Limited
Online
2017-09-26
DOI
10.1155/2017/9845175
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advanced glycation end products stimulate gene expression of fibroblast growth factor 23
- (2017) Ludmilla Bär et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Relationship between soluble receptor for advanced glycation end products (sRAGE), body composition and fat distribution in healthy women
- (2016) Elena Dozio et al. EUROPEAN JOURNAL OF NUTRITION
- Expression of the Receptor for Advanced Glycation End Products in Epicardial Fat: Link with Tissue Thickness and Local Insulin Resistance in Coronary Artery Disease
- (2016) Elena Dozio et al. Journal of Diabetes Research
- Soluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study
- (2015) Mariana Lazo et al. AMERICAN HEART JOURNAL
- Possible discrepancy of HbA1c values and its assessment among patients with chronic renal failure, hemodialysis and other diseases
- (2015) Kaori Inoue et al. Clinical and Experimental Nephrology
- Relationship Between Levels of Advanced Glycation End Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes
- (2015) Merlin C. Thomas et al. DIABETES CARE
- Uremic Toxicity of Advanced Glycation End Products in CKD
- (2015) A. E. M. Stinghen et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Chronic Kidney Disease: A Clinical Model of Premature Aging
- (2013) Peter Stenvinkel et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
- (2013) Benjamin D. Parker ANNALS OF INTERNAL MEDICINE
- Activation of receptor for advanced glycation end products contributes to aortic remodeling and endothelial dysfunction in sinoaortic denervated rats
- (2013) Feng Wu et al. ATHEROSCLEROSIS
- Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD
- (2013) Piera Boschetto et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)
- (2013) Giuseppe Mancia et al. JOURNAL OF HYPERTENSION
- Relation of Soluble Receptor for Advanced Glycation End Products to Predict Mortality in Patients With Chronic Heart Failure Independently of Seattle Heart Failure Score
- (2011) Sergio Raposeiras-Roubín et al. AMERICAN JOURNAL OF CARDIOLOGY
- Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysis
- (2011) Jwa-Kyung Kim et al. ATHEROSCLEROSIS
- Fibroblast Growth Factor 23, Cardiovascular Disease Risk Factors, and Phosphorus Intake in the Health Professionals Follow-up Study
- (2011) O. M. Gutierrez et al. Clinical Journal of the American Society of Nephrology
- Total Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products as Predictive Biomarkers of Coronary Heart Disease Risk in Patients With Type 2 Diabetes: An Analysis From the CARDS Trial
- (2011) H. M. Colhoun et al. DIABETES
- Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure
- (2011) Ling Jie Wang et al. EUROPEAN JOURNAL OF HEART FAILURE
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
- (2011) Tamara Isakova et al. KIDNEY INTERNATIONAL
- Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients
- (2011) L. Viaene et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD)
- (2011) D. Leonardis et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Fibroblast Growth Factor 23 and Disordered Vitamin D Metabolism in Chronic Kidney Disease: Updating the "Trade-off" Hypothesis
- (2010) O. M. Gutierrez Clinical Journal of the American Society of Nephrology
- Soluble receptor of advanced glycation end products levels are related to ischaemic aetiology and extent of coronary disease in chronic heart failure patients, independent of advanced glycation end products levels
- (2010) Sergio Raposeiras-Roubín et al. EUROPEAN JOURNAL OF HEART FAILURE
- FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease
- (2010) Mahmut I. Yilmaz et al. KIDNEY INTERNATIONAL
- FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment
- (2010) S. Seiler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- Soluble forms of RAGE in internal medicine
- (2009) Natale Vazzana et al. Internal and Emergency Medicine
- Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease
- (2009) Giuseppina Basta et al. KIDNEY INTERNATIONAL
- United States Renal Data System 2008 Annual Data Report Abstract
- (2008) Allan J. Collins et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Accumulation of Advanced Glycation End Products and Chronic Complications in ESRD Treated by Dialysis
- (2008) Robbert Meerwaldt et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Receptor for Advanced Glycation End Products
- (2008) Ravichandran Ramasamy et al. Annals of the New York Academy of Sciences
- Association between endogenous secretory RAGE, inflammatory markers and arterial stiffness
- (2008) K.M. Choi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Soluble Receptor for Advanced Glycation End Products (RAGE) is a Prognostic Factor for Heart Failure
- (2008) Yo Koyama et al. JOURNAL OF CARDIAC FAILURE
- Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications
- (2007) Giuseppina Basta ATHEROSCLEROSIS
- Diastolic Stiffness of the Failing Diabetic Heart
- (2007) Loek van Heerebeek et al. CIRCULATION
- Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes
- (2007) Kazuo Nakamura et al. MICROVASCULAR RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now